VIEMED HEALTHCARE, INC. Capital Expenditures Incurred but Not yet Paid
VIEMED HEALTHCARE, INC. (VMD) reported Capital Expenditures Incurred but Not yet Paid of $4.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $1.92M, a 482.12% increase year-over-year.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $2.88M, a 20.52% decline year-over-year.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$1.55M.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $819.00K, a 534.88% increase year-over-year.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $3.22M, a 47.82% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $2.18M, a 56.09% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $1.40M, a 88.90% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $739.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $4.80M 10-Q · filed 2026-08-03 | $3.25M derived: sum of 3 quarters · filed 2026-08-03 | $4.07M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $2.88M 10-Q · filed 2026-05-05 | $1.33M derived: sum of 2 quarters · filed 2026-05-05 | $2.15M derived: sum of 3 quarters · filed 2026-05-05 | $2.48M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$734.00K derived: sum of 2 quarters · filed 2026-03-04 | -$404.00K derived: sum of 3 quarters · filed 2026-08-03 | $3.22M 10-K · filed 2026-03-04 |
| 2025-09-30 | $819.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.15M derived: sum of 2 quarters · filed 2026-08-03 | $4.77M 10-Q · filed 2025-11-05 | $4.10M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.96M 10-Q · filed 2026-08-03 | $3.28M derived: sum of 3 quarters · filed 2026-08-03 | $3.41M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $3.63M 10-Q · filed 2026-05-05 | $2.95M derived: sum of 2 quarters · filed 2026-05-05 | $3.08M derived: sum of 3 quarters · filed 2026-05-05 | $3.38M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$546.00K derived: sum of 2 quarters · filed 2026-03-04 | -$249.00K derived: sum of 3 quarters · filed 2026-03-04 | $2.18M 10-K · filed 2026-03-04 |
| 2024-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $426.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.85M 10-Q · filed 2025-11-05 | $1.65M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.73M 10-Q · filed 2025-08-06 | $1.52M derived: sum of 3 quarters · filed 2026-03-04 | $1.59M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $2.43M 10-Q · filed 2025-05-07 | $1.23M derived: sum of 2 quarters · filed 2026-03-04 | $1.30M derived: sum of 3 quarters · filed 2026-03-04 | |
| 2023-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.13M derived: sum of 2 quarters · filed 2026-03-04 | $1.40M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.60M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $2.53M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $739.00K 10-K · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |